CLNE Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Management Efforts FFIN Q1 2026 Earnings EPS Beats Estimates by 38 WABC Q1 2026 Earnings EPS Beats Estimates as Interest Income Stability Offsets Margin Pressures Arcellx ACLX Q4 2025 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage GTES Q1 2026 Earnings EPS Beats Estimates by 47 Shares Edge Higher CLDI Q4 2025 Earnings Smallerthanexpected loss highlights progress in clinicalstage biotherapeutics